Sex and Survival After Surgery for Lung Cancer: A Swedish Nationwide Cohort

Erik Sachs, Ulrik Sartipy, Veronica Jackson, Erik Sachs, Ulrik Sartipy, Veronica Jackson

Abstract

Background: Prior reports on a possible female survival advantage in both surgical and nonsurgical cohorts of patients with lung cancer are conflicting. Previously reported differences in survival after lung cancer surgery could be the result of insufficient control for disparities in risk factor profiles in men and women.

Research question: Do women who undergo pulmonary resections for lung cancer have a better prognosis than men when taking a wide range of prognostic factors into account?

Study design and methods: We performed a nationwide population-based observational cohort study analyzing sex-specific survival after pulmonary resections for lung cancer. We identified 6356 patients from the Swedish National Quality Register for General Thoracic Surgery and performed individual-level record linkage to other national health-data registers to acquire detailed information regarding comorbidity, socioeconomic status, and vital status. Inverse probability of treatment weighting was used to account for differences in baseline characteristics. The association between female sex and all-cause mortality was assessed with Cox regression models, and flexible parametric survival models were used to estimate the absolute survival differences with 95% CIs. We also estimated the difference in restricted mean survival time.

Results: We observed a lower risk of death in women compared with men (hazard ratio, 0.73; 95% CI, 0.67-0.79). The absolute survival difference at 1, 5, and 10 years was 3.0% (95% CI, 2.2%-3.8%), 10% (95% CI, 7.0%-12%), and 12% (95% CI, 8.5%-15%), respectively. The restricted mean survival time difference at 10 years was 0.84 year (95% CI, 0.61-1.07 years). The findings were consistent across several subgroups.

Interpretation: Women who underwent pulmonary resections for lung cancer had a significantly better prognosis than men. The survival advantage was evident regardless of age, common comorbidities, socioeconomic status, lifestyle factors, physical performance, type and extent of surgery, tumor characteristics, and stage of disease.

Trial registry: ClinicalTrials.gov; No.: NCT03567538; URL: www.clinicaltrials.gov.

Keywords: epidemiology (pulmonary); lung cancer; sex; thoracic surgery.

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Figures

Figure 1
Figure 1
Kaplan-Meier estimated survival curve plotted against time from surgery and stratified according to sex. Male patients are the reference group. The numbers of patients at risk are not necessarily integers owing to inverse probability of treatment weighting. HR = hazard ratio.
Figure 2
Figure 2
A, Bar graph showing survival at 5 years in age categories according to sex. B, Hazard ratios and 95% CIs for the association between female sex and all-cause mortality in the unweighted (red) and weighted (blue) population in different age categories. Male patients are the reference group. IPTW = inverse probability of treatment weighting.
Figure 3
Figure 3
Kaplan-Meier estimated survival curves plotted against time from surgery and stratified according to sex in different subsets of patients. A, Adenocarcinoma. B, Squamous cell carcinoma. C, Stage IA and IB disease. D, Stage IIA and IIB disease. The numbers of patients at risk are not necessarily integers owing to inverse probability of treatment weighting. HR = hazard ratio.

References

    1. Afshar N., English D.R., Thursfield V. Differences in cancer survival by sex: a population-based study using cancer registry data. Cancer Causes Control. 2018 ;29(11):1059-1069.
    1. Micheli A., Ciampichini R., Oberaigner W. The advantage of women in cancer survival: an analysis of EUROCARE-4 data. Eur J Cancer. 2009;45(6):1017–1027.
    1. Radkiewicz C., Johansson A.L.V., Dickman P.W., Lambe M., Edgren G. Sex differences in cancer risk and survival: a Swedish cohort study. Eur J Cancer. 2017;84:130–140.
    1. Edgren G., Liang L., Adami H.O., Chang E.T. Enigmatic sex disparities in cancer incidence. Eur J Epidemiol. 2012;27(3):187–196.
    1. Wakelee H.A., Wang W., Schiller J.H. Survival differences by sex for patients with advanced non-small cell lung cancer on Eastern Cooperative Oncology Group trial 1594. J Thorac Oncol. 2006;1(5):441–446.
    1. Zang E.A., Wynder E.L. Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst. 1996;88(3-4):183–192.
    1. International Early Lung Cancer Action Program. Henschke C.I., Yip R., Miettinen O.S. Women’s susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer. JAMA. 2006;296(2):180–184.
    1. Batevik R., Grong K., Segadal L., Stangeland L. The female gender has a positive effect on survival independent of background life expectancy following surgical resection of primary non-small cell lung cancer: a study of absolute and relative survival over 15 years. Lung Cancer. 2005;47(2):173–181.
    1. Kinoshita F.L., Ito Y., Morishima T., Miyashiro I., Nakayama T. Sex differences in lung cancer survival: long-term trends using population-based cancer registry data in Osaka, Japan. Jpn J Clin Oncol. 2017;47(9):863–869.
    1. Nakamura H., Ando K., Shinmyo T. Female gender is an independent prognostic factor in non-small-cell lung cancer: a meta-analysis. Ann Thorac Cardiovasc Surg. 2011;17(5):469–480.
    1. Radkiewicz C., Dickman P.W., Johansson A.L.V., Wagenius G., Edgren G., Lambe M. Sex and survival in non-small cell lung cancer: a nationwide cohort study. PLoS One. 2019;14(6)
    1. Sagerup C.M., Smastuen M., Johannesen T.B., Helland A., Brustugun O.T. Sex-specific trends in lung cancer incidence and survival: a population study of 40,118 cases. Thorax. 2011;66(4):301–307.
    1. Visbal A.L., Williams B.A., Nichols F.C., III Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002. Ann Thorac Surg. 2004;78(1):209–215. discussion 215.
    1. Wainer Z., Wright G.M., Gough K. Sex-dependent staging in non-small-cell lung cancer; analysis of the effect of sex differences in the eighth edition of the tumor, node, metastases staging system. Clin Lung Cancer. 2018;19(6):e933–e944.
    1. Bugge A., Kongerud J., Brunborg C., Solberg S., Lund M.B. Gender-specific survival after surgical resection for early stage non-small cell lung cancer. Acta Oncol. 2017;56(3):448–454.
    1. Jubelirer S.J., Varela N.L., Welch C.A., Emmett M.K. Does sex make a difference in survival of patients undergoing resection for early stage non-small cell lung cancer (NSCLC)? W V Med J. 2009;105(4):18–22.
    1. Benchimol E.I., Smeeth L., Guttmann A. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12(10)
    1. von Elm E., Altman D.G., Egger M. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344–349.
    1. ThoR The Swedish National Quality Register for General Thoracic Surgery. Uppsala Clinical Research Center website.
    1. Ludvigsson J.F., Otterblad-Olausson P., Pettersson B.U., Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24(11):659–667.
    1. Ludvigsson J.F., Andersson E., Ekbom A. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.
    1. Ludvigsson J.F., Svedberg P., Olen O., Bruze G., Neovius M. The Longitudinal Integrated Database for Health Insurance and Labour Market Studies (LISA) and its use in medical research. Eur J Epidemiol. 2019;34(4):423–437.
    1. Ludvigsson J.F., Almqvist C., Bonamy A.K. Registers of the Swedish total population and their use in medical research. Eur J Epidemiol. 2016;31(2):125–136.
    1. Oken M.M., Creech R.H., Tormey D.C. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–655.
    1. Griffin B.A., Ridgeway G., Morral A. Toolkit for Weighting and Analysis of Nonequivalent Groups (TWANG). Rand Corporation website. 2014. Accessed June 27, 2020.
    1. Ridgeway G., McCaffrey D., Morral A., Griffin B.A., Burgette L. twang: Toolkit for Weighting and Analysis of Nonequivalent Groups. 2017. The Comprehensive R Archive Network website. Accessed June 27, 2020.
    1. Austin P.C., Stuart E.A. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34(28):3661–3679.
    1. Lambert P.C., Royston P. Further development of flexible parametric models for survival analysis. Stata J. 2009;9(2):265–290.
    1. Kim D.H., Uno H., Wei L.J. Restricted mean survival time as a measure to interpret clinical trial results. JAMA Cardiol. 2017;2(11):1179–1180.
    1. Royston P., Parmar M.K. Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome. BMC Med Res Methodol. 2013;13:152.
    1. Minami H., Yoshimura M., Miyamoto Y., Matsuoka H., Tsubota N. Lung cancer in women: sex-associated differences in survival of patients undergoing resection for lung cancer. Chest. 2000;118(6):1603–1609.
    1. Arnold B.N., Thomas D.C., Rosen J.E. Lung cancer in the very young: treatment and survival in the National Cancer Data Base. J Thorac Oncol. 2016;11(7):1121–1131.
    1. Zhang Y.B., Pan X.F., Chen J. Combined lifestyle factors, incident cancer, and cancer mortality: a systematic review and meta-analysis of prospective cohort studies. Br J Cancer. 2020;122(7):1085–1093.
    1. Public Health Agency of Sweden Public health development. Public Health Agency of Sweden website.
    1. The Institute for Health Metrics and Evaluation (IHME) Country profiles—Sweden 2017. Institute for Health Metrics and Evaluation website. Accessed June 27, 2020.
    1. Global Burden of Disease Causes of Death Collaborators Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–1788.
    1. Yoshida Y., Murayama T., Sato Y., Suzuki Y., Saito H., Nomura Y. Gender differences in long-term survival after surgery for non-small cell lung cancer. Thorac Cardiovasc Surg. 2016;64(6):507–514.
    1. Fritz I., Olsson H. Lung cancer in young women in southern Sweden: a descriptive study. Clin Respir J. 2018;12(4):1565–1571.
    1. Powell H.A., Iyen-Omofoman B., Hubbard R.B., Baldwin D.R., Tata L.J. The association between smoking quantity and lung cancer in men and women. Chest. 2013;143(1):123–129.
    1. Yu Y., Liu H., Zheng S. Gender susceptibility for cigarette smoking-attributable lung cancer: a systematic review and meta-analysis. Lung Cancer. 2014;85(3):351–360.
    1. Ostergren O., Martikainen P., Tarkiainen L., Elstad J.I., Bronnum-Hansen H. Contribution of smoking and alcohol consumption to income differences in life expectancy: evidence using Danish, Finnish, Norwegian and Swedish register data. J Epidemiol Community Health. 2019;73(4):334–339.
    1. Statistics Sweden Average length of life. Statistics Sweden website.
    1. Ostergren O., Martikainen P. The contribution of smoking-related deaths to the gender gap in life expectancy in Sweden between 1997 and 2016. Scand J Public Health. 2020;48(3):346–349.
    1. Dalton S.O., Steding-Jessen M., Jakobsen E. Socioeconomic position and survival after lung cancer: influence of stage, treatment and comorbidity among Danish patients with lung cancer diagnosed in 2004-2010. Acta Oncol. 2015;54(5):797–804.
    1. Sachs E., Jackson V., Sartipy U. Household disposable income and long-term survival after pulmonary resections for lung cancer. Thorax. 2020 ;75(9):764-770.
    1. Willen L., Berglund A., Bergstrom S. Educational level and management and outcomes in non-small cell lung cancer. A nationwide population-based study. Lung Cancer. 2019;131:40–46.
    1. Public Health Agency of Sweden Public health development. Public Health Agency of Sweden website. Accessed June 27, 2020.
    1. Beard E., Brown J., West R., Kaner E., Meier P., Michie S. Associations between socio-economic factors and alcohol consumption: a population survey of adults in England. PLoS One. 2019;14(2)
    1. Troche J.R., Mayne S.T., Freedman N.D., Shebl F.M., Abnet C.C. The association between alcohol consumption and lung carcinoma by histological subtype. Am J Epidemiol. 2016;183(2):110–121.
    1. Paull D.E., Updyke G.M., Davis C.A., Adebonojo S.A. Complications and long-term survival for alcoholic patients with resectable lung cancer. Am J Surg. 2004;188(5):553–559.
    1. Graf S.A., Zeliadt S.B., Rise P.J., Backhus L.M., Zhou X.H., Williams E.C. Unhealthy alcohol use is associated with postoperative complications in veterans undergoing lung resection. J Thorac Dis. 2018;10(3):1648–1656.
    1. Neuenschwander A.U., Pedersen J.H., Krasnik M., Tonnesen H. Impaired postoperative outcome in chronic alcohol abusers after curative resection for lung cancer. Eur J Cardiothorac Surg. 2002;22(2):287–291.
    1. Green A., Hauge J., Iachina M., Jakobsen E. The mortality after surgery in primary lung cancer: results from the Danish Lung Cancer Registry. Eur J Cardiothorac Surg. 2016;49(2):589–594.
    1. Armenian S.H., Xu L., Ky B. Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study. J Clin Oncol. 2016;34(10):1122–1130.
    1. Liu X., Hemminki K., Forsti A., Sundquist K., Sundquist J., Ji J. Cancer risk in patients with type 2 diabetes mellitus and their relatives. Int J Cancer. 2015;137(4):903–910.
    1. Strongman H., Gadd S., Matthews A. Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases. Lancet. 2019;394(10203):1041–1054.
    1. Zoller B., Ji J., Sundquist J., Sundquist K. Risk of coronary heart disease in patients with cancer: a nationwide follow-up study from Sweden. Eur J Cancer. 2012;48(1):121–128.
    1. Tseng C.H. Diabetes but not insulin increases the risk of lung cancer: a Taiwanese population-based study. PLoS One. 2014;9(7)
    1. Huang W.Y., Li C.H., Lin C.L., Liang J.A. Long-term statin use in patients with lung cancer and dyslipidemia reduces the risk of death. Oncotarget. 2016;7(27):42208–42215.
    1. Kwon Y.J., You N.Y., Lee J.W., Kim J., Kang H.T. High receipt of statins reduces the risk of lung cancer in current smokers with hypercholesterolemia: the National Health Insurance Service-Health Screening Cohort. Clin Lung Cancer. 2019;20(2):e177–e185.
    1. Woodard G.A., Jones K.D., Jablons D.M. Lung cancer staging and prognosis. Cancer Treat Res. 2016;170:47–75.
    1. Chansky K., Sculier J.P., Crowley J.J. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer. J Thorac Oncol. 2009;4(7):792–801.
    1. Watanabe K., Sakamaki K., Nishii T. Gender differences in the recurrence timing of patients undergoing resection for non-small cell lung cancer. Asian Pac J Cancer Prev. 2018;19(3):719–724.
    1. Chen P.C., Muo C.H., Lee Y.T., Yu Y.H., Sung F.C. Lung cancer and incidence of stroke: a population-based cohort study. Stroke. 2011;42(11):3034–3039.
    1. Al-Ameri M., Bergman P., Franco-Cereceda A., Sartipy U. Video-assisted thoracoscopic versus open thoracotomy lobectomy: a Swedish nationwide cohort study. J Thorac Dis. 2018;10(6):3499–3506.
    1. Bendixen M., Jorgensen O.D., Kronborg C., Andersen C., Licht P.B. Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer: a randomised controlled trial. Lancet Oncol. 2016;17(6):836–844.
    1. Dziedzic R., Marjanski T., Binczyk F., Polanska J., Sawicka W., Rzyman W. Favourable outcomes in patients with early-stage non-small-cell lung cancer operated on by video-assisted thoracoscopic surgery: a propensity score-matched analysis. Eur J Cardiothorac Surg. 2018;54(3):547–553.
    1. Cao C., Frick A.E., Ilonen I. European questionnaire on the clinical use of video-assisted thoracoscopic surgery. Interact Cardiovasc Thorac Surg. 2018;27(3):379–383.
    1. Li X., Wang J., Ferguson M.K. Competence versus mastery: the time course for developing proficiency in video-assisted thoracoscopic lobectomy. J Thorac Cardiovasc Surg. 2014;147(4):1150–1154.
    1. Postmus P.E., Kerr K.M., Oudkerk M. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(suppl 4):iv1–iv21.
    1. Pawelczyk K., Blasiak P., Szromek M., Nowinska K., Marciniak M. Assessment of adequacy of intraoperative nodal staging and factors influencing the lack of its compliance with recommendations in the surgical treatment of non-small cell lung cancer (NSCLC) J Thorac Dis. 2018;10(8):4902–4911.
    1. Hay K., McDougal L., Percival V. Disrupting gender norms in health systems: making the case for change. Lancet. 2019;393(10190):2535–2549.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera